Woo Yunseo, Lee Hyo-Ji, Jung Young Mee, Jung Yu-Jin
Department of Biological Sciences, Kangwon National University, Chuncheon 24341, Korea.
Kangwon Radiation Convergence Research Support Center, Kangwon National University, Chuncheon 24341, Korea.
Cells. 2020 Dec 17;9(12):2709. doi: 10.3390/cells9122709.
The treatment of tumors requires the induction of cell death. Radiotherapy, chemotherapy, and immunotherapy are administered to kill cancer cells; however, some cancer cells are resistant to these therapies. Therefore, effective treatments require various strategies for the induction of cell death. Regulated cell death (RCD) is systematically controlled by intracellular signaling proteins. Apoptosis and autophagy are types of RCD that are morphologically different from necrosis, while necroptosis, pyroptosis, and ferroptosis are morphologically similar to necrosis. Unlike necrosis, regulated necrotic cell death (RNCD) is caused by disruption of the plasma membrane under the control of specific proteins and induces tissue inflammation. Various types of RNCD, such as necroptosis, pyroptosis, and ferroptosis, have been used as therapeutic strategies against various tumor types. In this review, the mechanisms of necroptosis, pyroptosis, and ferroptosis are described in detail, and a potential effective treatment strategy to increase the anticancer effects on apoptosis- or autophagy-resistant tumor types through the induction of RNCD is suggested.
肿瘤的治疗需要诱导细胞死亡。放疗、化疗和免疫疗法用于杀死癌细胞;然而,一些癌细胞对这些疗法具有抗性。因此,有效的治疗需要多种诱导细胞死亡的策略。程序性细胞死亡(RCD)由细胞内信号蛋白进行系统性调控。凋亡和自噬是程序性细胞死亡的类型,它们在形态上与坏死不同,而坏死性凋亡、炎性小体介导的细胞焦亡和铁死亡在形态上与坏死相似。与坏死不同,程序性坏死性细胞死亡(RNCD)是由特定蛋白质控制下的质膜破坏引起的,并会诱导组织炎症。多种类型的程序性坏死性细胞死亡,如坏死性凋亡、炎性小体介导的细胞焦亡和铁死亡,已被用作针对各种肿瘤类型的治疗策略。在这篇综述中,详细描述了坏死性凋亡、炎性小体介导的细胞焦亡和铁死亡的机制,并提出了一种潜在的有效治疗策略,即通过诱导程序性坏死性细胞死亡来增强对凋亡或自噬抗性肿瘤类型的抗癌效果。